TradingView
Amit_Ghosh
Aug 18, 2018 8:20 PM

Natco Pharma Results Compression Bet - Investment Idea Long

NATCO PHARMA LTDNSE

Description

Fundamentally
Posted amazing results. Not appreciated and forward factored while outlook remains same.
Technically
It is at swing low with amazing risk to reward.

Comment

Valuation wise it is cheaper than its peers by a large scale. Hence, I will say it is undervalued at this price. Fundamentally we can expect double valuation from current levels.
Comments
virend539
Q4 net profit 300 cr while Q1 was merely 181 similarly sales 768 cr 9 Q4) to 539 cr (Q1)
good company 52.1 % profit growth in 5 yrs healthy dividend consistent
virend539
Recently Q1 result was bad compared to Q4
Amit_Ghosh
@virend539, Thanks for pointing. I will dig out. Actually this dude was going up and up but ended in cyclic stock when this news came moneycontrol.com/news/business/earnings/natco-pharma-q1-net-profit-up-93-to-rs-181-crore-2822731.html. So swing is still vaild though. Maybe it will stay cyclic for a period.
More